Identification of transcription factor co-regulators that drive prostate cancer progression
Abstract In prostate cancer (PCa), and many other hormone-dependent cancers, there is clear evidence for distorted transcriptional control as disease driver mechanisms. Defining which transcription factor (TF) and coregulators are altered and combine to become oncogenic drivers remains a challenge,...
Guardado en:
Autores principales: | Manjunath Siddappa, Sajad A. Wani, Mark D. Long, Damien A. Leach, Ewy A. Mathé, Charlotte L. Bevan, Moray J. Campbell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4631e065a23b463eb4e0b14a0f46990a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
por: Charlotte L. Bevan
Publicado: (2021) -
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yota Yasumizu, et al.
Publicado: (2020) -
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
por: Victor Laurent, et al.
Publicado: (2016) -
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
por: Svitlana Tyekucheva, et al.
Publicado: (2017) -
CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance
por: Koran S. Harris, et al.
Publicado: (2021)